The inflammatory microenvironment in colorectal Neoplasia

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  McLean, Mairi H ^a   Murray, Graeme I ^a   Stewart, Keith N ^a   Norrie, Gillian ^b   Mayer, Claus ^c   Hold, Georgina L ^a   Thomson, John ^a   Fyfe, Nicky ^a   Hope, Mairi ^a   Mowat, N Ashley G ^a   Drew, Janice E ^c   El Omar, Emad M ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CCL23 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; RANTES; SECONDARY LYMPHOID TISSUE CHEMOKINE; UNCLASSIFIED DRUG; CYTOKINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON ADENOMA; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DYSPLASIA; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; NEUTROPHIL; PHENOTYPE; T LYMPHOCYTE; TUMOR MICROENVIRONMENT; ADENOMA; COLON POLYP; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; PRECANCER; PROGNOSIS; TUMOR ASSOCIATED LEUKOCYTE;

ADENOMA; COLONIC POLYPS; COLORECTAL NEOPLASMS; CYTOKINES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR MICROENVIRONMENT;

EID: 79251580670     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015366     Document Type: Article

References (52)

1. Cancer Research UK. Cancer statistics. Available at: www.cancerresearchuk.org.
2. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
3. Mantovani A, Romero P, Palucka AK, Marincola FM (2008) Tumour immunity: effector response to tumour and role of the microenvironment. Lancet 371: 771-783.
4. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130: 1091-1103.
5. Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, et al. (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313: 1960-1964.
6. DeNardo DG, Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 9: 212.
7. McLean MH, Murray GI, Fyfe N, Hold GL, Mowat NA, et al. (2008) COX-2 expression in sporadic colorectal adenomatous polyps is linked to adenoma characteristics. Histopathology 52: 806-815.
8. Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, et al. (2005) Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11: 3758-3765.
9. Munder M, Eichmann K, Moran JM, Centeno F, Soler G, et al. (1999) Th1/ Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells. J Immunol 163: 3771-3777.
10. Mosser DM (2003) The many faces of macrophage activation. J Leukoc Biol 73: 209-212.
11. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433.
12. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408.
13. Ishiko T, Mita S, Hidaka H, Kamohara H, Ikeda O, et al. (2003) Human carcinoma cells express IL-8 and IL-8 receptor: their role and regulation in cancer biology. International Congress Series 1255: 327-332.
14. Kitadai Y, Takahashi Y, Haruma K, Naka K, Sumii K, et al. (1999) Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 81: 647-653.
15. Mian BM, Dinney CP, Bermejo CE, Sweeney P, Tellez C, et al. (2003) Fully human anti-interleukin 8 antibody inhibits tumor growth in orthotopic bladder cancer xenografts via down-regulation of matrix metalloproteases and nuclear factor-kappaB. Clin Cancer Res 9: 3167-3175.
16. Rubie C, Oliveira V, Kempf K, Wagner M, Tilton B, et al. (2006) Involvement of chemokine receptor CCR6 in colorectal cancer metastasis. Tumour Biol 27: 166-174.
17. Wen Y, Giardina SF, Hamming D, Greenman J, Zachariah E, et al. (2006) GROalpha is highly expressed in adenocarcinoma of the colon and downregulates fibulin-1. Clin Cancer Res 12: 5951-5959.
18. Wang D, Wang H, Brown J, Daikoku T, Ning W, et al. (2006) CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J Exp Med 203: 941-951.
19. Forssmann U, Delgado MB, Uguccioni M, Loetscher P, Garotta G, et al. (1997) CKbeta8, a novel CC chemokine that predominantly acts on monocytes. FEBS Lett 408: 211-216.
20. Shih CH, van Eeden SF, Goto Y, Hogg JC (2005) CCL23/myeloid progenitor inhibitory factor-1 inhibits production and release of polymorphonuclear leukocytes and monocytes from the bone marrow. Exp Hematol 33: 1101-1108.
21. Hwang J, Son KN, Kim CW, Ko J, Na DS, et al. (2005) Human CC chemokine CCL23, a ligand for CCR1, induces endothelial cell migration and promotes angiogenesis. Cytokine 30: 254-263.
22. Son KN, Hwang J, Kwon BS, Kim J (2006) Human CC chemokine CCL23 enhances expression of matrix metalloproteinase-2 and invasion of vascular endothelial cells. Biochem Biophys Res Commun 340: 498-504.
23. Vaday GG, Peehl DM, Kadam PA, Lawrence DM (2006) Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66: 124-134.
24. Sutton A, Friand V, Papy-Garcia D, Dagouassat M, Martin L, et al. (2007) Glycosaminoglycans and their synthetic mimetics inhibit RANTES-induced migration and invasion of human hepatoma cells.Mol Cancer Ther 6: 2948-2958.
25. Baier PK, Eggstein S, Wolff-Vorbeck G, Baumgartner U, Hopt UT (2005) Chemokines in human colorectal carcinoma. Anticancer Res 25: 3581-3584.
26. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, et al. (1999) Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J Exp Med 189: 451-460.
27. Mori S, Nakano H, Aritomi K, Wang CR, Gunn MD, et al. (2001) Mice lacking expression of the chemokines CCL21-ser and CCL19 (plt mice) demonstrate delayed but enhanced T cell immune responses. J Exp Med 193: 207-218.
28. Ichikawa Y, Ishikawa T, Takahashi S, Hamaguchi Y, Morita T, et al. (2002) Identification of genes regulating colorectal carcinogenesis by using the algorithm for diagnosing malignant state method. Biochem Biophys Res Commun 296: 497-506.
29. Tang ZQ, Han LY, Lin HH, Cui J, Jia J, et al. (2007) Derivation of stablemicroarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation. Cancer Res 67: 9996-10003.
30. Daemen A, Gevaert O, De Bie T, Debucquoy A, Machiels JP, et al. (2008) Integrating microarray and proteomics data to predict the response on cetuximab in patients with rectal cancer. Pac Symp Biocomput. pp 166-177.
31. Notterman DA, Alon U, Sierk AJ, Levine AJ (2001) Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 61: 3124-3130.
32. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC, et al. (2002) Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 21: 4120-4128.
33. Kita H, Hikichi Y, Hikami K, Tsuneyama K, Cui ZG, et al. (2006) Differential gene expression between flat adenoma and normal mucosa in the colon in a microarray analysis. J Gastroenterol 41: 1053-1063.
34. Sillars-Hardebol AH, Carvalho B, de Wit M, et al. (2010) Identification of key genes for carcinogenic pathways associated with colorectal adenoma-tocarcinoma progression. Tumour Biol 31: 89-96.
35. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
36. MacDonald TT (2003) The mucosal immune system. Parasite immunology 25: 235-246.
37. Wittig BM, Zeitz M (2003) The Gut as an organ of immunology. International Journal of Colorectal Disease 18: 181-187.
38. Grisham MB, Ware K, Gilleland HE, Jr., Gilleland LB, Abell CL, et al. (1992) Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats. Gastroenterology 103: 1260-1266.
39. Vermeer IT, Henderson LY, Moonen EJ, Engels LG, Dallinga JW, et al. (2004) Neutrophil-mediated formation of carcinogenic N-nitroso compounds in an in vitro model for intestinal inflammation.
40. Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
41. Jeffery N, McLean MH, El-Omar EM, Murray GI (2009) The matrix metalloproteinase/tissue inhibitor of matrix metalloproteinase profile in colorectal polyp cancers. Histopathology 54: 820-828.
42. Jablonska J, Leschner S, Westphal K, Lienenklaus S, Weiss S (2010) Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. J Clin Invest 120: 1151-1164.
43. Sun Z, Yang P (2004) Role of imbalance between neutrophil elastase and alpha 1-antitrypsin in cancer development and progression. Lancet Oncol 5: 182-190.
44. Starcher B, O'Neal P, Granstein RD, Beissert S (1996) Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice. J Invest Dermatol 107: 159-163.
45. Kamohara H, Sakamoto K, Mita S, An XY, Ogawa M (1997) Neutrophil elastase inhibitor (ONO-5046.Na) suppresses the proliferation, motility and chemotaxis of a pancreatic carcinoma cell line, Capan-1. Res Commun Mol Pathol Pharmacol 98: 103-108.
46. Inada M, Yamashita J, Ogawa M (1997) Neutrophil elastase inhibitor (ONO- 5046-Na) inhibits the growth of human lung cancer cell lines transplanted into severe combined immunodeficiency (scid) mice. Res Commun Mol Pathol Pharmacol 97: 229-232.
47. Campregher C, Luciani MG, Gasche C (2008) Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13- repeat in colon epithelial cells. Gut 57: 780-787.
48. Dinapoli MR, Calderon CL, Lopez DM (1996) The altered tumoricidal capacity of macrophages isolated from tumor-bearing mice is related to reduce expression of the inducible nitric oxide synthase gene. J Exp Med 183: 1323-1329.
49. Thun MJ, Namboodiri MM, Heath CW, Jr. (1991) Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325: 1593-1596.
50. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, et al. (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348: 891-899.
51. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, et al. (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348: 883-890.
52. Benamouzig R, Deyra J, Martin A, Girard B, Jullian E, et al. (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125: 328-336.